{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:22:21Z","timestamp":1790356941324,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,1,6]],"date-time":"2016-01-06T00:00:00Z","timestamp":1452038400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China (CN)","doi-asserted-by":"publisher","award":["81273580, 81473280"],"award-info":[{"award-number":["81273580, 81473280"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s13277-015-4478-8","type":"journal-article","created":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T22:41:07Z","timestamp":1452033667000},"page":"8587-8597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Targeting P-glycoprotein expression and cancer cell energy metabolism: combination of metformin and 2-deoxyglucose reverses the multidrug resistance of K562\/Dox cells to doxorubicin"],"prefix":"10.1007","volume":"37","author":[{"given":"Chaojun","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokui","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,6]]},"reference":[{"key":"4478_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2014.11.002","author":"RJ Kathawala","year":"2014","unstructured":"Kathawala RJ, Gupta P, Ashby Jr CR, Chen Z. The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade : reviews and commentaries in antimicrobial and anticancer chemotherapy. Drug Resist Updat. 2014. doi: 10.1016\/j.drup.2014.11.002 .","journal-title":"Drug Resist Updat"},{"issue":"13\u201314","key":"4478_CR2","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.addr.2013.07.012","volume":"65","author":"AK Iyer","year":"2013","unstructured":"Iyer AK, Singh A, Ganta S, Amiji MM. Role of integrated cancer nanomedicine in overcoming drug resistance. Adv Drug Deliv Rev. 2013;65(13\u201314):1784\u2013802. doi: 10.1016\/j.addr.2013.07.012 .","journal-title":"Adv Drug Deliv Rev"},{"key":"4478_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2014.11.013","author":"R Silva","year":"2014","unstructured":"Silva R, Vilas-Boas V, Carmo H, Dinis-Oliveira RJ, Carvalho F, de Lourdes BM, et al. Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy. Pharmacol Ther. 2014. doi: 10.1016\/j.pharmthera.2014.11.013 .","journal-title":"Pharmacol Ther"},{"issue":"1","key":"4478_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002;2(1):48\u201358. doi: 10.1038\/nrc706 .","journal-title":"Nat Rev Cancer"},{"issue":"7\u20138","key":"4478_CR5","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1080\/00498250701867889.","volume":"38","author":"S-F Zhou","year":"2008","unstructured":"Zhou S-F. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica. 2008;38(7\u20138):802\u201332. doi: 10.1080\/00498250701867889. .","journal-title":"Xenobiotica"},{"issue":"1","key":"4478_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jare.2014.11.008","volume":"6","author":"HM Abdallah","year":"2015","unstructured":"Abdallah HM, Al-Abd AM, El-Dine RS, El-Halawany AM. P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: a review. J Adv Res. 2015;6(1):45\u201362. doi: 10.1016\/j.jare.2014.11.008 .","journal-title":"J Adv Res"},{"issue":"3","key":"4478_CR7","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1254\/jphs.14R01CR","volume":"125","author":"T Kobori","year":"2014","unstructured":"Kobori T, Harada S, Nakamoto K, Tokuyama S. Mechanisms of P-glycoprotein alteration during anticancer treatment: role in the pharmacokinetic and pharmacological effects of various substrate drugs. J Pharmacol Sci. 2014;125(3):242\u201354.","journal-title":"J Pharmacol Sci"},{"issue":"6","key":"4478_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3978\/j.issn.2305-5839.2014.06.01","volume":"2","author":"J Kasznicki","year":"2014","unstructured":"Kasznicki J, Sliwinska A, Drzewoski J. Metformin in cancer prevention and therapy. Ann Transl Med. 2014;2(6):57. doi: 10.3978\/j.issn.2305-5839.2014.06.01 .","journal-title":"Ann Transl Med"},{"issue":"3","key":"4478_CR9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1158\/1055-9965.epi-08-0871","volume":"18","author":"M Cazzaniga","year":"2009","unstructured":"Cazzaniga M, Bonanni B, Guerrieri-Gonzaga A, Decensi A. Is it time to test metformin in breast cancer clinical trials? Cancer Epidemiol Biomarkers Prev. 2009;18(3):701\u20135. doi: 10.1158\/1055-9965.epi-08-0871 .","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"4478_CR10","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/01.EPX.0000456620.00173.c0","volume":"89","author":"SA El-Benhawy","year":"2014","unstructured":"El-Benhawy SA, El-Sheredy HG. Metformin and survival in diabetic patients with breast cancer. J Egypt Public Health Assoc. 2014;89(3):148\u201353. doi: 10.1097\/01.EPX.0000456620.00173.c0 .","journal-title":"J Egypt Public Health Assoc"},{"issue":"2","key":"4478_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ygyno.2014.12.001","volume":"136","author":"EM Ko","year":"2015","unstructured":"Ko EM, Sturmer T, Hong JL, Castillo WC, Bae-Jump V, Funk MJ. Metformin and the risk of endometrial cancer: a population-based cohort study. Gynecol Oncol. 2015;136(2):341\u20137. doi: 10.1016\/j.ygyno.2014.12.001 .","journal-title":"Gynecol Oncol"},{"issue":"2","key":"4478_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.lungcan.2014.09.012","volume":"86","author":"MJ Tsai","year":"2014","unstructured":"Tsai MJ, Yang CJ, Kung YT, Sheu CC, Shen YT, Chang PY, et al. Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner. Lung Cancer. 2014;86(2):137\u201343. doi: 10.1016\/j.lungcan.2014.09.012 .","journal-title":"Lung Cancer"},{"key":"4478_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2015.02.007","author":"ZH Maayah","year":"2015","unstructured":"Maayah ZH, Ghebeh H, Alhaider AA, El-Kadi AO, Soshilov AA, Denison MS, et al. Metformin inhibits 7,12-dimethylbenz[a]anthracene-induced breast carcinogenesis and adduct formation in human breast cells by inhibiting the cytochrome P4501A1\/aryl hydrocarbon receptor signaling pathway. Toxicol Appl Pharmacol. 2015. doi: 10.1016\/j.taap.2015.02.007 .","journal-title":"Toxicol Appl Pharmacol"},{"key":"4478_CR14","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2015.2903","author":"S Fujihara","year":"2015","unstructured":"Fujihara S, Kato K, Morishita A, Iwama H, Nishioka T, Chiyo T, et al. Antidiabetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo. Int J Oncol. 2015. doi: 10.3892\/ijo.2015.2903 .","journal-title":"Int J Oncol"},{"issue":"5","key":"4478_CR15","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/j.1476-5381.2010.01101.x","volume":"162","author":"HG Kim","year":"2011","unstructured":"Kim HG, Hien TT, Han EH, Hwang YP, Choi JH, Kang KW, et al. Metformin inhibits P-glycoprotein expression via the NF-kappaB pathway and CRE transcriptional activity through AMPK activation. Br J Pharmacol. 2011;162(5):1096\u2013108. doi: 10.1111\/j.1476-5381.2010.01101.x .","journal-title":"Br J Pharmacol"},{"issue":"2","key":"4478_CR16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0014-5793(89)81380-8","volume":"247","author":"HJ Broxterman","year":"1989","unstructured":"Broxterman HJ, Pinedo HM, Kuiper CM, Schuurhuis GJ, Lankelma J. Glycolysis in P-glycoprotein-overexpressing human tumor cell lines. Effects of resistance-modifying agents. FEBS Lett. 1989;247(2):405\u201310.","journal-title":"FEBS Lett"},{"issue":"3","key":"4478_CR17","first-page":"544","volume":"50","author":"O Kaplan","year":"1990","unstructured":"Kaplan O, Navon G, Lyon RC, Faustino PJ, Straka EJ, Cohen JS. Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism. Cancer Res. 1990;50(3):544\u201351.","journal-title":"Cancer Res"},{"key":"4478_CR18","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-062613-093128","author":"DR Morales","year":"2014","unstructured":"Morales DR, Morris AD. Metformin in cancer treatment and prevention. Annu Rev Med. 2014. doi: 10.1146\/annurev-med-062613-093128 .","journal-title":"Annu Rev Med"},{"issue":"6","key":"4478_CR19","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1158\/0008-5472.can-09-2782","volume":"70","author":"I Ben Sahra","year":"2010","unstructured":"Ben Sahra I, Laurent K, Giuliano S, Larbret F, Ponzio G, Gounon P, et al. Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells. Cancer Res. 2010;70(6):2465\u201375. doi: 10.1158\/0008-5472.can-09-2782 .","journal-title":"Cancer Res"},{"issue":"3\u20134","key":"4478_CR20","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.ejps.2013.08.010","volume":"50","author":"X Huo","year":"2013","unstructured":"Huo X, Liu Q, Wang C, Meng Q, Sun H, Peng J, et al. Enhancement effect of P-gp inhibitors on the intestinal absorption and antiproliferative activity of bestatin. Eur J Pharm Sci. 2013;50(3\u20134):420\u20138. doi: 10.1016\/j.ejps.2013.08.010 .","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"4478_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4161\/15384047.2014.987062","volume":"16","author":"T Chen","year":"2015","unstructured":"Chen T, Wang C, Liu Q, Meng Q, Sun H, Huo X, et al. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway. Cancer biology ther. 2015;16(1):106\u201314. doi: 10.4161\/15384047.2014.987062 .","journal-title":"Cancer biology ther"},{"issue":"2","key":"4478_CR22","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s11095-014-1483-3","volume":"32","author":"X Chen","year":"2015","unstructured":"Chen X, Meng Q, Wang C, Liu Q, Sun H, Huo X, et al. Protective effects of calycosin against CCl4-induced liver injury with activation of FXR and STAT3 in mice. Pharm Res. 2015;32(2):538\u201348. doi: 10.1007\/s11095-014-1483-3 .","journal-title":"Pharm Res"},{"issue":"4","key":"4478_CR23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2133\/dmpk.DMPK-09-RG-092","volume":"25","author":"Q Meng","year":"2010","unstructured":"Meng Q, Liu Q, Wang C, Sun H, Kaku T, Kato Y, et al. Molecular mechanisms of biliary excretion of cefditoren and the effects of cefditoren on the expression levels of hepatic transporters. Drug Metab Pharmacokinet. 2010;25(4):320\u20137.","journal-title":"Drug Metab Pharmacokinet"},{"issue":"2","key":"4478_CR24","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/jps.23805","volume":"103","author":"X Huo","year":"2014","unstructured":"Huo X, Liu Q, Wang C, Meng Q, Sun H, Peng J, et al. Inhibitory effect of valsartan on the intestinal absorption and renal excretion of bestatin in rats. J Pharm Sci. 2014;103(2):719\u201329. doi: 10.1002\/jps.23805 .","journal-title":"J Pharm Sci"},{"key":"4478_CR25","doi-asserted-by":"publisher","unstructured":"Rumjanek VM, Vidal RS, Maia RC. Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR-CML cell lines? Biosci Rep. 2013;33(6). doi: 10.1042\/BSR20130067 .","DOI":"10.1042\/BSR20130067"},{"issue":"8","key":"4478_CR26","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/sj.bjc.6605912","volume":"103","author":"M Gerlinger","year":"2010","unstructured":"Gerlinger M, Swanton C. How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine. Br J Cancer. 2010;103(8):1139\u201343. doi: 10.1038\/sj.bjc.6605912 .","journal-title":"Br J Cancer"},{"key":"4478_CR27","first-page":"227","volume":"643","author":"AB Shapiro","year":"1998","unstructured":"Shapiro AB, Ling V. The mechanism of ATP-dependent multidrug transport by P-glycoprotein. Acta Physiol Scand Suppl. 1998;643:227\u201334.","journal-title":"Acta Physiol Scand Suppl"},{"issue":"4","key":"4478_CR28","doi-asserted-by":"publisher","first-page":"383.e1","DOI":"10.1016\/j.ajog.2010.01.035","volume":"202","author":"SJ Hemauer","year":"2010","unstructured":"Hemauer SJ, Patrikeeva SL, Nanovskaya TN, Hankins GD, Ahmed MS. Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin. Am J Obstet Gynecol. 2010;202(4):383.e1\u20137. doi: 10.1016\/j.ajog.2010.01.035 .","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"4478_CR29","first-page":"687","volume":"82","author":"Y Canitrot","year":"1995","unstructured":"Canitrot Y, Lautier D. Use of rhodamine 123 for the detection of multidrug resistance. Bull Cancer. 1995;82(9):687\u201397.","journal-title":"Bull Cancer"},{"issue":"12","key":"4478_CR30","doi-asserted-by":"publisher","first-page":"e114573","DOI":"10.1371\/journal.pone.0114573","volume":"9","author":"M Ming","year":"2014","unstructured":"Ming M, Sinnett-Smith J, Wang J, Soares HP, Young SH, Eibl G, et al. Dose-dependent AMPK-dependent and independent mechanisms of berberine and metformin inhibition of mTORC1, ERK, DNA synthesis and proliferation in pancreatic cancer cells. PLoS One. 2014;9(12):e114573. doi: 10.1371\/journal.pone.0114573 .","journal-title":"PLoS One"},{"issue":"12","key":"4478_CR31","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1007\/s00726-014-1838-4","volume":"46","author":"SC Hsieh","year":"2014","unstructured":"Hsieh SC, Tsai JP, Yang SF, Tang MJ, Hsieh YH. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK\/JNK-mediated NF-kappaB-dependent pathway that reduces uPA and MMP-9 expression. Amino Acids. 2014;46(12):2809\u201322. doi: 10.1007\/s00726-014-1838-4 .","journal-title":"Amino Acids"},{"issue":"2","key":"4478_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.taap.2013.05.010","volume":"271","author":"MT Do","year":"2013","unstructured":"Do MT, Kim HG, Khanal T, Choi JH, Kim DH, Jeong TC, et al. Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways. Toxicol Appl Pharmacol. 2013;271(2):229\u201338. doi: 10.1016\/j.taap.2013.05.010 .","journal-title":"Toxicol Appl Pharmacol"},{"issue":"12","key":"4478_CR33","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1096\/fj.02-0541com","volume":"16","author":"ME Harper","year":"2002","unstructured":"Harper ME, Antoniou A, Villalobos-Menuey E, Russo A, Trauger R, Vendemelio M, et al. Characterization of a novel metabolic strategy used by drug-resistant tumor cells. FASEB J. 2002;16(12):1550\u20137. doi: 10.1096\/fj.02-0541com .","journal-title":"FASEB J"},{"issue":"5","key":"4478_CR34","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1089\/ars.2011.4410","volume":"17","author":"A Hamacher-Brady","year":"2012","unstructured":"Hamacher-Brady A. Autophagy regulation and integration with cell signaling. Antioxid Redox Signal. 2012;17(5):756\u201365. doi: 10.1089\/ars.2011.4410 .","journal-title":"Antioxid Redox Signal"},{"key":"4478_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.rvsc.2015.02.002","author":"SS Yang","year":"2015","unstructured":"Yang SS, Zheng MX, Xu HC, Cui XZ, Zhang Y, Zhao WL, et al. The effect of mitochondrial ATP-sensitive potassium channels on apoptosis of chick embryo cecal cells by Eimeria tenella. Res Vet Sci. 2015. doi: 10.1016\/j.rvsc.2015.02.002 .","journal-title":"Res Vet Sci"},{"issue":"4","key":"4478_CR36","doi-asserted-by":"publisher","first-page":"E188","DOI":"10.1002\/ijc.29158","volume":"136","author":"Y Kam","year":"2015","unstructured":"Kam Y, Das T, Tian H, Foroutan P, Ruiz E, Martinez G, et al. Sweat but no gain: inhibiting proliferation of multidrug resistant cancer cells with \u201cersatzdroges\u201d. Int J Cancer. 2015;136(4):E188\u201396. doi: 10.1002\/ijc.29158 .","journal-title":"Int J Cancer"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4478-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-4478-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4478-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T11:43:46Z","timestamp":1559475826000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-4478-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,6]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["4478"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-4478-8","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,6]]}}}